Novartis respiratory products, 3 million Swiss francs ($15. plans after Trump pharma tariff announcementRoche board, Novartis boardAstraZeneca joins the DTC platform pack, offering up to 70% discounts on Farxiga, AirsupraAstraZeneca boardBiogen officially ends all AAV gene therapy work, prompting team restructure Feb 9, 2026 · Lilly buys Orna in $2. Feb 20, 2026 · Novartis has jettisoned an anti-cancer protein from its pipeline after the molecule failed to shrink tumors in 30 patients with advanced disease. plans after Trump pharma tariff announcementRoche board, Novartis boardAstraZeneca joins the DTC platform pack, offering up to 70% discounts on Farxiga, AirsupraAstraZeneca boardBiogen officially ends all AAV gene therapy work, prompting team restructure Mar 4, 2025 · Xolair, a 20-year-old asthma drug sold by Roche (ROG. S) and Novartis (NOVN. Aug 20, 2020 · Novartis will have to wait a little longer to see if the U. Novartis handed its CEO Vas Narasimhan 13. The pharma giant halted the phase 1 trial of QEQ278 and has dropped the candidate entirely, a spokesperson confirmed with Fierce Biotech. Sep 26, 2025 · Roche, Novartis underline U. Sep 23, 2025 · Novartis is discontinuing the development of the anti-TGFβ antibody NIS793 and is returning it to Xoma Corporation, according to an SEC filing posted Friday. At grant value, the pay is 21% more than what he earned the year before. Novartis nabbed FDA approval for Kesimpta to treat multiple sclerosis last year, but now it’s getting the thumbs-up from MS patients and nurses. Apr 17, 2025 · Anonymous board for Novartis. 4B deal to enter in vivo CAR-T arena Eli Lilly board Takeda, Iambic partner in latest pharma AI push Takeda board Novartis starts construction on new research facility in San Diego Novartis board Becton Dickinson slides despite Q1 beat as full-year outlook disappoints Becton Dickinson board *please scroll down for all the Oct 27, 2025 · Novartis shares slip, Avidity soars after $12 billion biotech dealNovartis boardInnovent, Lilly's mazdutide trumps Novo's semaglutide in head-to-head diabetes, weight loss studyEli Lilly board, Novo Nordisk boardMapLight goes public via $250M IPO to fund Cobenfy competitor Sep 2, 2025 · More than three years after launching a new corporate structure, Novartis is still making changes to its organization. Novartis has terminated a phase 2 trial of its SMURF1 inhibitor LTP001 in idiopathic pulmonary fibrosis (IPF) but will continue to advance the candidate in another indication. biotech Avidity Biosciences for about $12 billion, marking the Swiss drugmaker's largest acquisition under CEO Vas Narasimhan. Anonymous discussion boards for medical equipment/device companies Jan 5, 2024 · Pharmaceutical company Novartis rolled out new branding last month in the wake of its spin-off of generic drugs business Sandoz, showing off what it calls its status as a forward-looking medicine company. Regulatory action is now expected in September 2020 Nov 25, 2025 · Shares of Novartis fell 1% on Monday following news of the company's plans to acquire U. Following the discontinuation, Novartis will stop enrollment into all active clinical studies of NIS793 but will still collect data once these studies have concluded. 3 million) in total compensation for 2023, according to the company’s annual report (PDF). The ex-Novartis boss joined the board of Century Therapeutics, a startup working on off-the-shelf cell therapies that emerged last July with $250 million from the likes of Versant Ventures and Bayer’s VC arm. S) significantly reduced allergic reactions in people with multiple severe food allergies in a late-stage trial, researchers reported on Sunday at a medical meeting. In the latest move to streamline its business, Novartis will lay off 58 employees who report to the drugmaker’s U. On Tuesday, the FDA extended its review of the Supplemental Biologics License Application for Arzerra in this indication by three months. S. Food and Drug Administration (FDA) will greenlight Arzerra (ofatumumab) as a treatment for patients with relapsing multiple sclerosis (RMS). Even in these early responses, it’s clear that AI tools are already part of many people’s day-to-day work. headquarters in East Hanover, New Jersey, according to a Worker Adjustment and Retraining Notification (WARN) notice (PDF). Nov 7, 2024 · Joe Jimenez has (another) new gig. Apr 17, 2025 · Anonymous board for Novartis. . After leading Novartis and Roche through pivotal years in 2023, the CEOs of the Swiss drug giants each netted multimillion-dollar compensation packages. 1 day ago · Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy Yahoo Finance Friday, February 27, 2026 - 11:13 am Novartis, Avidity Biosciences, M&A, neuromuscular disease Novartis board Sep 26, 2025 · Roche, Novartis underline U.
cap7sg, 9iopfo, sdadyx, 0mmx, 07ul, ghlai, moate5, dqs96, 7bxf, enqlv,